Deepan Selvadurai, M.D.

Buffalo Glaucoma Specialist and Cataract Surgeon

Dr. Deepan Selvadurai is a fellowship-trained and board-certified cataract and glaucoma specialist. Known for adopting advanced technologies and treatment methods early, he specializes in the management of complex cases and prioritizes patient education throughout the care journey.

Education & Experience

Bachelor of Science in Microbiology and Immunology – McGill University
Doctor of Medicine (M.D.) – Rosalind Franklin University of Medicine and Science (Dean’s Award)
Internship – Northwestern University
Residency (Chief Resident) – The Mayo Clinic
Fellowship – The University of Toronto

Accomplishments

Among the first in the U.S. to perform minimally invasive glaucoma surgery (MIGS) with the OMNI® Surgical System.
One of the first to perform dropless cataract surgery, reducing post-op medication use for patients.
Known for a personalized, informative approach that ensures patients fully understand their procedures and feel confident in their care.
Board Certified by the American Board of Ophthalmology.

Professional Memberships

Member – American Academy of Ophthalmology
Member – American Glaucoma Society
Former President & Current Member – Buffalo Ophthalmology Society

Community Involvement & Interests

Dr. Selvadurai is committed to global and local eye care outreach. He has delivered laser treatments for glaucoma and diabetic retinopathy in St. Vincent and the Grenadines and worked with the ORBIS Flying Eye Hospital in Nigeria and Kenya. Locally, he supports organizations that provide vision care to underserved populations and sponsors various community and youth groups.

He is fluent in French, Spanish, and Tamil, and enjoys cycling and spending time with his family.

Publications & Media Recognition

Canaloplasty and Trabeculotomy with the OMNI System in Patients with Open-Angle Glaucoma: Two-Year Results from the ROMEO Study. Clinical Ophthalmology, 2023
Canaloplasty and trabeculotomy with the OMNI® surgical system in OAG with prior trabecular microbypass stenting. International Ophthalmology, 2023
Canaloplasty and trabeculotomy ab interno with the OMNI system combined with cataract surgery in open-angle glaucoma: 12-month outcomes from the ROMEO study. Journal of Cataract and Refractive Surgery, 2021
Canaloplasty and Trabeculotomy ab interno with the OMNI System Combined with Cataract Surgery in Open-Angle Glaucoma: 12-month Outcomes from the ROMEO Study. Journal of Cataract and Refractive Surgery, 2020
Aqueous humor outflow facility by tonography does not change with body position. Investigative Ophthalmology and Visual Science, 2010
American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma. Ophthalmology, 2009
Corneal abnormalities in incontinentia pigmenti: histopathological and confocal correlations. Cornea, 2008